Understanding Accutane Dragon Pharma
Accutane Dragon Pharma is a pharmaceutical-grade isotretinoin formulation designed exclusively for controlled laboratory research applications. This retinoid compound enables researchers at Stroid UK Shop to investigate vitamin A derivative pathways and their cellular mechanisms in dermatological studies. The compound’s high bioavailability profile makes it valuable for examining retinoid receptor interactions and sebaceous gland function in cellular models. Isotretinoin represents a critical tool for understanding how retinoid signalling pathways influence keratinocyte differentiation and lipid metabolism in laboratory settings.
Scientific Research Applications
Laboratory investigations utilising isotretinoin examine multiple cellular pathways including retinoic acid receptor (RAR) and retinoid X receptor (RXR) modulation. Researchers analyse how this compound affects gene expression patterns related to cell proliferation, differentiation, and apoptosis in various tissue models. Studies frequently examine isotretinoin’s influence on sebaceous gland activity and keratinisation processes through controlled in-vitro experiments. The compound’s potent retinoid activity enables detailed investigation of vitamin A metabolism and its downstream effects on cellular signalling cascades. Research teams investigating dermatological compounds utilise isotretinoin to understand complex interactions between retinoid receptors and transcriptional regulation mechanisms. Advanced laboratories studying skin biology examine how isotretinoin modulates inflammatory cytokine production and affects cellular immune responses. Comparative studies alongside selective receptor modulators provide insights into tissue-specific retinoid effects. Research applications extend to investigating isotretinoin’s influence on collagen synthesis pathways and extracellular matrix remodelling in cellular models. Scientists examining cellular signalling compounds often incorporate isotretinoin studies to understand broader receptor-mediated pathways.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 13-cis-retinoic acid |
| CAS Number | 4759-48-2 |
| Molecular Formula | C₂₀H₂₈O₂ |
| Molecular Weight | 300.44 g/mol |
| Purity | Verify with supplier |
| Form | Capsules |
| Storage Conditions | Room temperature, protected from light |
| Solubility | Lipophilic, oil-soluble |
Regulatory Compliance
This product is manufactured exclusively for in-vitro research purposes and laboratory analytical applications. Accutane Dragon Pharma is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory safety protocols and comply with institutional guidelines for retinoid compound handling. All studies should be conducted within approved research facilities with proper ventilation and safety equipment. This material is supplied for legitimate scientific research only and requires appropriate licensing for laboratory use.
